Abstract
Objective: To evaluate the predictors of the risk of long-term hospital readmission after radical prostatectomy (RP) in a single tertiary referral center where both open RP (ORP) and robot assisted RP (RARP) are performed. Materials and Methods: The risk of readmission was evaluated by clinical, pathological, and perioperative factors. Skilled and experienced surgeons performed the 2 surgical approaches. Patients were followed for complications and hospital readmission for a period of 6 months. The association of factors with the risk of readmission was assessed by Cox’s multivariate proportional hazards. Results: From December 2013 to 2017, 885 patients underwent RP. RARP was performed in 733 cases and ORP in 152 subjects. Extended pelvic lymph node dissection (ePLND) was performed in 479 patients. Hospital readmission was detected in 46 cases (5.2%). Using a multivariate model, independent factors associated with the risk of hospital readmission were seminal vesicle invasion (hazard ratio [HR] 2.065; 95% CI 1.116–3.283; p = 0.021), ORP (HR 3.506; 95% CI 1.919–6.405; p < 0.0001), and ePLND (HR 5.172; 95% CI 1.778–15.053; p < 0.0001). Conclusions: In a large single tertiary referral center, independent predictors of the risk of long-term hospital readmission after RP included ORP, ePLND, and seminal vesicle invasion. When surgery is chosen as a primary treatment of PCA, patients should be informed of the risk of long-term hospital readmission and its related risk factors.
References
1.
Ferlay
J
, Soerjomataram
I
, Dikshit
R
, Eser
S
, Mathers
C
, Rebelo
M
, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
. Int J Cancer
. 2015
Mar
;136
(5
):E359
–86
.
[PubMed]
0020-71362.
Mottet
N
, Bellmunt
J
, Bolla
M
, Briers
E
, Cumberbatch
MG
, De Santis
M
, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent
. Eur Urol
. 2017
Apr
;71
(4
):618
–29
.
[PubMed]
0302-28383.
Oberlin
DT
, Flum
AS
, Lai
JD
, Meeks
JJ
. The effect of minimally invasive prostatectomy on practice patterns of American urologists. Urologic Oncology: Seminars and Original Investigations
. Elsevier
; 2016
.4.
Dindo
D
, Demartines
N
, Clavien
PA
. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey
. Ann Surg
. 2004
Aug
;240
(2
):205
–13
.
[PubMed]
0003-49325.
Mitropoulos
D
, Artibani
W
, Graefen
M
, Remzi
M
, Rouprêt
M
, Truss
M
; European Association of Urology Guidelines Panel
. Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations
. Eur Urol
. 2012
Feb
;61
(2
):341
–9
.
[PubMed]
0302-28386.
Moschini
M
, Gandaglia
G
, Fossati
N
, Dell’Oglio
P
, Cucchiara
V
, Luzzago
S
, et al. Incidence and Predictors of 30-Day Readmission After Robot-Assisted Radical Prostatectomy
. Clin Genitourin Cancer
. 2017
Feb
;15
(1
):67
–71
.
[PubMed]
1558-76737.
Xia
L
, Taylor
BL
, Pulido
JE
, Mucksavage
P
, Lee
DI
, Guzzo
TJ
. Predischarge Predictors of Readmissions and Postdischarge Complications in Robot-Assisted Radical Prostatectomy
. J Endourol
. 2017
Sep
;31
(9
):864
–71
.
[PubMed]
0892-77908.
Wallerstedt Lantz
, A.
and J.
Stranne
, 90-Day readmission after radical prostatectomy-a prospective comparison between robot-assisted and open surgery. 2019
; 53: 26-33.9.
Jencks
SF
, Williams
MV
, Coleman
EA
. Rehospitalizations among patients in the Medicare fee-for-service program
. N Engl J Med
. 2009
Apr
;360
(14
):1418
–28
.
[PubMed]
0028-479310.
Vest
JR
, Gamm
LD
, Oxford
BA
, Gonzalez
MI
, Slawson
KM
. Determinants of preventable readmissions in the United States: a systematic review
. Implement Sci
. 2010
Nov
;5
(1
):88
.
[PubMed]
1748-590811.
McIlvennan
CK
, Eapen
ZJ
, Allen
LA
. Hospital readmissions reduction program
. Circulation
. 2015
May
;131
(20
):1796
–803
.
[PubMed]
0009-732212.
Lucas
DJ
, Haider
A
, Haut
E
, Dodson
R
, Wolfgang
CL
, Ahuja
N
, et al. Assessing readmission after general, vascular, and thoracic surgery using ACS-NSQIP
. Ann Surg
. 2013
Sep
;258
(3
):430
–9
.
[PubMed]
0003-493213.
Menon
M
, Tewari
A
, Peabody
J
; VIP Team
. Vattikuti Institute prostatectomy: technique
. J Urol
. 2003
Jun
;169
(6
):2289
–92
.
[PubMed]
0022-534714.
Walsh
PC
. Anatomic radical prostatectomy: evolution of the surgical technique
. J Urol
. 1998
Dec
;160
(6 Pt 2
):2418
–24
.
[PubMed]
0022-534715.
Briganti
A
, Larcher
A
, Abdollah
F
, Capitanio
U
, Gallina
A
, Suardi
N
, et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores
. Eur Urol
. 2012
Mar
;61
(3
):480
–7
.
[PubMed]
0302-283816.
Porcaro
AB
, Inverardi
D
, Corsi
P
, Sebben
M
, Cacciamani
G
, Tafuri
A
, et al. Prostate specific antigen levels and proportion of biopsy positive cores are independent predictors of upgrading patterns in low risk prostate cancer
. Minerva Urol Nefrol
. 2018
Oct
;
[PubMed]
1827-175817.
Porcaro
AB
, Cavicchioli
F
, Mattevi
D
, De Luyk
N
, Corsi
P
, Sebben
M
, et al. Clinical factors of disease reclassification or progression in a contemporary cohort of prostate cancer patients elected to active surveillance
. Urol Int
. 2017
;98
(1
):32
–9
.
[PubMed]
0042-113818.
Porcaro
AB
, de Luyk
N
, Corsi
P
, Sebben
M
, Tafuri
A
, Mattevi
D
, et al. Clinical factors predicting and stratifying the risk of lymph node invasion in localized prostate cancer
. Urol Int
. 2017
;99
(2
):207
–14
.
[PubMed]
0042-113819.
Porcaro
AB
, De Luyk
N
, Corsi
P
, Sebben
M
, Tafuri
A
, Processali
T
, et al. Association between basal total testosterone levels and tumor upgrading in low and intermediate risk prostate cancer
. Urol Int
. 2017
;99
(2
):215
–21
.
[PubMed]
0042-113820.
Porcaro
AB
, Siracusano
S
, Luyk
N
, Corsi
P
, Sebben
M
, Tafuri
A
, et al. Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer
. Tumori
. 2018
Mar-Apr
;104
(2
):111
–5
.
[PubMed]
0300-891621.
Porcaro
AB
, Tafuri
A
, Sebben
M
, Corsi
P
, Pocessali
T
, Pirozzi
M
, et al. Positive Association between Preoperative Total Testosterone Levels and Risk of Positive Surgical Margins by Prostate Cancer: Results in 476 Consecutive Patients Treated Only by Radical Prostatectomy
. Urol Int
. 2018
;101
(1
):38
–46
.
[PubMed]
0042-113822.
Porcaro
AB
, Cacciamani
GE
, Sebben
M
, Tafuri
A
, Processali
T
, Rizzetto
R
, et al. Lymph Nodes Invasion of Marcille’s Fossa Associates with High Metastatic Load in Prostate Cancer Patients Undergoing Extended Pelvic Lymph Node Dissection: The Role of “Marcillectomy”
. Urol Int
. 2019
;103
(1
):25
–32
.
[PubMed]
0042-113823.
Cacciamani
GE
, Porcaro
AB
, Sebben
M
, Tafuri
A
, Rizzetto
R
, De Luyk
N
, et al. Extended pelvic lymphadenectomy for prostate cancer: should the Cloquet’s nodes dissection be considered only an option?
Minerva Urol Nefrol
. 2019
Apr
;71
(2
):136
–45
.
[PubMed]
0393-224924.
Porcaro
AB
, Tafuri
A
, Novella
G
, Sebben
M
, Mariotto
A
, Inverardi
D
, et al. Inverse Association of Prostatic Chronic Inflammation among Prostate Cancer Tumor Grade Groups: retrospective study of 738 consecutive cases elected to a first random biopsy set
. Urol Int
. 2018
;100
(4
):456
–62
.
[PubMed]
0042-113825.
Epstein
JI
, Egevad
L
, Amin
MB
, Delahunt
B
, Srigley
JR
, Humphrey
PA
; Grading Committee
. The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma
. Am J Surg Pathol
. 2016
Feb
;40
(2
):244
–52
.
[PubMed]
1532-097926.
Pierorazio
PM
, Walsh
PC
, Partin
AW
, Epstein
JI
. Prognostic Gleason grade grouping: data based on the modified Gleason scoring system
. BJU Int
. 2013
May
;111
(5
):753
–60
.
[PubMed]
1464-409627.
Srigley
JR
, Humphrey
PA
, Amin
MB
, Chang
SS
, Egevad
L
, Epstein
JI
, et al.; Members of the Cancer Committee, College of American Pathologists
. Protocol for the examination of specimens from patients with carcinoma of the prostate gland
. Arch Pathol Lab Med
. 2009
Oct
;133
(10
):1568
–76
.
[PubMed]
1543-216528.
Chung
SD
, Kelle
JJ
, Huang
CY
, Chen
YH
, Lin
HC
. Comparison of 90-day re-admission rates between open retropubic radical prostatectomy (RRP), laparoscopic RP (LRP) and robot-assisted laparoscopic prostatectomy (RALP)
. BJU Int
. 2012
Dec
;110
(11c
11 Pt C
):E966
–71
.
[PubMed]
1464-409629.
Friðriksson
JÖ
, Holmberg
E
, Adolfsson
J
, Lambe
M
, Bill-Axelson
A
, Carlsson
S
, et al. Rehospitalization after radical prostatectomy in a nationwide, population based study
. J Urol
. 2014
Jul
;192
(1
):112
–9
.
[PubMed]
0022-534730.
Gandaglia
G
, Bravi
CA
, Dell’Oglio
P
, Mazzone
E
, Fossati
N
, Scuderi
S
, et al. The Impact of Implementation of the European Association of Urology Guidelines Panel Recommendations on Reporting and Grading Complications on Perioperative Outcomes after Robot-assisted Radical Prostatectomy
. Eur Urol
. 2018
Jul
;74
(1
):4
–7
.
[PubMed]
0302-283831.
Pereira
JF
, Golijanin
D
, Pareek
G
, Guo
R
, Zhang
Z
, Renzulli
J
2nd, et al. The association of age with perioperative morbidity and mortality among men undergoing radical prostatectomy
. Urol Oncol
. 2018
Apr
;36
(4
):157.e7
–13
.
[PubMed]
1078-143932.
Pilecki
MA
, McGuire
BB
, Jain
U
, Kim
JY
, Nadler
RB
. National multi-institutional comparison of 30-day postoperative complication and readmission rates between open retropubic radical prostatectomy and robot-assisted laparoscopic prostatectomy using NSQIP
. J Endourol
. 2014
Apr
;28
(4
):430
–6
.
[PubMed]
0892-779033.
Yaxley
JW
, Coughlin
GD
, Chambers
SK
, Occhipinti
S
, Samaratunga
H
, Zajdlewicz
L
, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study
. Lancet
. 2016
Sep
;388
(10049
):1057
–66
.
[PubMed]
0140-673634.
Brito
, J.
, 3rd, J.
Pereira
and D.M.
Moreira
, The association of lymph node dissection with 30-day perioperative morbidity among men undergoing minimally invasive radical prostatectomy: analysis of the National Surgical Quality Improvement Program (NSQIP). 2018
; 21: 245-251.35.
Fracalanza
S
, Ficarra
V
, Cavalleri
S
, Galfano
A
, Novara
G
, Mangano
A
, et al. Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Results from a prospective, unrandomized, comparative study
. BJU Int
. 2008
May
;101
(9
):1145
–9
.
[PubMed]
1464-409636.
Porcaro
AB
, de Luyk
N
, Corsi
P
, Sebben
M
, Tafuri
A
, Inverardi
D
, et al. Robotic assisted radical prostatectomy accelerates postoperative stress recovery: final results of a contemporary prospective study assessing pathophysiology of cortisol peri-operative kinetics in prostate cancer surgery
. Asian J Urol
. 2016
Apr
;3
(2
):88
–95
.
[PubMed]
2214-388237.
Porcaro
AB
, Molinari
A
, Terrin
A
, De Luyk
N
, Baldassarre
R
, Brunelli
M
, et al. Robotic-assisted radical prostatectomy is less stressful than the open approach: results of a contemporary prospective study evaluating pathophysiology of cortisol stress-related kinetics in prostate cancer surgery
. J Robot Surg
. 2015
Sep
;9
(3
):249
–55
.
[PubMed]
1863-248338.
Keskin
MS
, Argun
OB
, Öbek
C
, Tufek
I
, Tuna
MB
, Mourmouris
P
, et al. The incidence and sequela of lymphocele formation after robot-assisted extended pelvic lymph node dissection
. BJU Int
. 2016
Jul
;118
(1
):127
–31
.
[PubMed]
1464-409639.
Gotto
GT
, Yunis
LH
, Guillonneau
B
, Touijer
K
, Eastham
JA
, Scardino
PT
, et al. Predictors of symptomatic lymphocele after radical prostatectomy and bilateral pelvic lymph node dissection
. Int J Urol
. 2011
Apr
;18
(4
):291
–6
.
[PubMed]
0919-817240.
Fukuda
H
, Yamada
T
, Kamata
S
, Saitoh
H
. Anatomic distribution of intraprostatic lymphatics: implications for the lymphatic spread of prostate cancer-a preliminary study
. Prostate
. 2000
Sep
;44
(4
):322
–7
.
[PubMed]
0270-413741.
Villers
AA
, McNeal
JE
, Redwine
EA
, Freiha
FS
, Stamey
TA
. Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma
. J Urol
. 1990
Jun
;143
(6
):1183
–7
.
[PubMed]
0022-534742.
Gil-Vernet
JM
. Prostate cancer: anatomical and surgical considerations
. Br J Urol
. 1996
Aug
;78
(2
):161
–8
.
[PubMed]
0007-133143.
Porcaro
AB
, de Luyk
N
, Corsi
P
, Sebben
M
, Tafuri
A
, Tamanini
I
, et al. Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer
. Tumori
. 2017
May
;103
(3
):299
–306
.
[PubMed]
0300-891644.
Montorsi
F
, Wilson
TG
, Rosen
RC
, Ahlering
TE
, Artibani
W
, Carroll
PR
, et al.; Pasadena Consensus Panel
. Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel
. Eur Urol
. 2012
Sep
;62
(3
):368
–81
.
[PubMed]
0302-283845.
Porcaro
AB
, Borsato
A
, Romano
M
, Sava
T
, Ghimenton
C
, Migliorini
F
, et al. Accuracy of preoperative endo-rectal coil magnetic resonance imaging in detecting clinical under-staging of localized prostate cancer
. World J Urol
. 2013
Oct
;31
(5
):1245
–51
.
[PubMed]
0724-498346.
Porcaro
AB
, Sebben
M
, Tafuri
A
, de Luyk
N
, Corsi
P
, Processali
T
, et al. Body mass index is an independent predictor of Clavien-Dindo grade 3 complications in patients undergoing robot assisted radical prostatectomy with extensive pelvic lymph node dissection
. J Robot Surg
. 2019
Feb
;13
(1
):83
–9
.
[PubMed]
1863-248347.
Porcaro
AB
, Tafuri
A
, Sebben
M
, Processali
T
, Pirozzi
M
, Amigoni
N
, et al. Body Mass Index and prostatic specific antigen are independent predictors of multiple prostate cancer lymph node metastases in Caucasian patients undergoing robot assisted radical prostatectomy and extended pelvic lymph node dissection
. Minerva Urol Nefrol
. 2019
. 0393-224948.
Porcaro
AB
, Tafuri
A
, Sebben
M
, Processali
T
, Pirozzi
M
, Amigoni
N
, et al. High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection
. Asian J Androl
. 2019
Jul
;0
(0
):0
.
[PubMed]
1008-682X© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
